FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310258737> ?p ?o ?g. }

• W4310258737 endingPage "288" @default.
• W4310258737 startingPage "280" @default.
• W4310258737 abstract "Abstract Background Recently, with the advent of sofosbuvir/velpatasvir therapy, sustained virological response (SVR) can now be achieved even in patients with decompensated cirrhosis (dLC). However, the prognosis after SVR does not always improve in dLC, and appropriate indicators enabling prediction of prognosis is desired. Patients and methods Serum IP‐10/CXCL10 levels were measured in 47 patients (15 chronic hepatitis [CH], 17 compensated cirrhosis [cLC], and 15 dLC) receiving direct acting antiviral (DAA) therapy, and their changes during the therapy were examined. Results All the patients achieved SVR. In patients with CH, the average IP‐10 level was 367, 102, and 68 pg/ml respectively at baseline, at the end of therapy and at 12 weeks after SVR (SVR12), and was decreased upon DAA therapy ( P < 0.001). In patients with cLC, IP‐10 was respectively 215, 91, and 77 pg/ml, and was decreased upon DAA therapy ( P < 0.001) while it was 283, 131, and 182 pg/ml in patients with dLC and there was no evident decrease ( P = 0.55). When patients with dLC were further classified depending on the difference in Child–Pugh (CP) score improvement at SVR12, a significant decrease in IP‐10 was observed after treatment in those with improvement ( P = 0.023) while a significant increase was observed in those without improvement ( P = 0.016). Conclusion While serum IP‐10 level was decreased in patients with CH/cLC and dLC with post‐SVR‐CP improvement following SVR, it was increased in patients with dLC without post‐SVR CP improvement. The result indicates that IP‐10 dynamics may be useful for predicting liver function after DAA therapy." @default.
• W4310258737 created "2022-11-30" @default.
• W4310258737 creator A5000038288 @default.
• W4310258737 creator A5003573363 @default.
• W4310258737 creator A5008196968 @default.
• W4310258737 creator A5008540110 @default.
• W4310258737 creator A5010668249 @default.
• W4310258737 creator A5014285573 @default.
• W4310258737 creator A5018951423 @default.
• W4310258737 creator A5029452450 @default.
• W4310258737 creator A5030644327 @default.
• W4310258737 creator A5043413343 @default.
• W4310258737 creator A5047039182 @default.
• W4310258737 creator A5053860058 @default.
• W4310258737 creator A5058386183 @default.
• W4310258737 creator A5063234735 @default.
• W4310258737 creator A5065539827 @default.
• W4310258737 creator A5073094281 @default.
• W4310258737 creator A5089548236 @default.
• W4310258737 date "2022-12-13" @default.
• W4310258737 modified "2023-10-15" @default.
• W4310258737 title "Significance of serum IP‐10/CXCL10 measurement in predicting post‐direct acting antiviral treatment liver function in patients with HCV‐decompensated liver cirrhosis" @default.
• W4310258737 cites W1982882530 @default.
• W4310258737 cites W2001360631 @default.
• W4310258737 cites W2010681459 @default.
• W4310258737 cites W2052834898 @default.
• W4310258737 cites W2119544585 @default.
• W4310258737 cites W2130858592 @default.
• W4310258737 cites W2165899828 @default.
• W4310258737 cites W2266909385 @default.
• W4310258737 cites W2563439282 @default.
• W4310258737 cites W2736582179 @default.
• W4310258737 cites W2790202686 @default.
• W4310258737 cites W2894741983 @default.
• W4310258737 cites W2898378712 @default.
• W4310258737 cites W2922250370 @default.
• W4310258737 cites W2964835591 @default.
• W4310258737 cites W2994844142 @default.
• W4310258737 cites W3031498534 @default.
• W4310258737 cites W3086846242 @default.
• W4310258737 cites W3092292188 @default.
• W4310258737 doi "https://doi.org/10.1111/hepr.13861" @default.
• W4310258737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36445119" @default.
• W4310258737 hasPublicationYear "2022" @default.
• W4310258737 type Work @default.
• W4310258737 citedByCount "2" @default.
• W4310258737 countsByYear W43102587372022 @default.
• W4310258737 countsByYear W43102587372023 @default.
• W4310258737 crossrefType "journal-article" @default.
• W4310258737 hasAuthorship W4310258737A5000038288 @default.
• W4310258737 hasAuthorship W4310258737A5003573363 @default.
• W4310258737 hasAuthorship W4310258737A5008196968 @default.
• W4310258737 hasAuthorship W4310258737A5008540110 @default.
• W4310258737 hasAuthorship W4310258737A5010668249 @default.
• W4310258737 hasAuthorship W4310258737A5014285573 @default.
• W4310258737 hasAuthorship W4310258737A5018951423 @default.
• W4310258737 hasAuthorship W4310258737A5029452450 @default.
• W4310258737 hasAuthorship W4310258737A5030644327 @default.
• W4310258737 hasAuthorship W4310258737A5043413343 @default.
• W4310258737 hasAuthorship W4310258737A5047039182 @default.
• W4310258737 hasAuthorship W4310258737A5053860058 @default.
• W4310258737 hasAuthorship W4310258737A5058386183 @default.
• W4310258737 hasAuthorship W4310258737A5063234735 @default.
• W4310258737 hasAuthorship W4310258737A5065539827 @default.
• W4310258737 hasAuthorship W4310258737A5073094281 @default.
• W4310258737 hasAuthorship W4310258737A5089548236 @default.
• W4310258737 hasConcept C126322002 @default.
• W4310258737 hasConcept C13373296 @default.
• W4310258737 hasConcept C170493617 @default.
• W4310258737 hasConcept C203014093 @default.
• W4310258737 hasConcept C2522874641 @default.
• W4310258737 hasConcept C2777214474 @default.
• W4310258737 hasConcept C2778390639 @default.
• W4310258737 hasConcept C2780040827 @default.
• W4310258737 hasConcept C2992208098 @default.
• W4310258737 hasConcept C2993512173 @default.
• W4310258737 hasConcept C3020491458 @default.
• W4310258737 hasConcept C5858377 @default.
• W4310258737 hasConcept C71924100 @default.
• W4310258737 hasConcept C90924648 @default.
• W4310258737 hasConceptScore W4310258737C126322002 @default.
• W4310258737 hasConceptScore W4310258737C13373296 @default.
• W4310258737 hasConceptScore W4310258737C170493617 @default.
• W4310258737 hasConceptScore W4310258737C203014093 @default.
• W4310258737 hasConceptScore W4310258737C2522874641 @default.
• W4310258737 hasConceptScore W4310258737C2777214474 @default.
• W4310258737 hasConceptScore W4310258737C2778390639 @default.
• W4310258737 hasConceptScore W4310258737C2780040827 @default.
• W4310258737 hasConceptScore W4310258737C2992208098 @default.
• W4310258737 hasConceptScore W4310258737C2993512173 @default.
• W4310258737 hasConceptScore W4310258737C3020491458 @default.
• W4310258737 hasConceptScore W4310258737C5858377 @default.
• W4310258737 hasConceptScore W4310258737C71924100 @default.
• W4310258737 hasConceptScore W4310258737C90924648 @default.
• W4310258737 hasFunder F4320311405 @default.
• W4310258737 hasIssue "4" @default.
• W4310258737 hasLocation W43102587371 @default.
• W4310258737 hasLocation W43102587372 @default.

• next